Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries by Amstutz, Patrick et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2006
Rapid selection of specific MAP kinase-binders from designed ankyrin repeat
protein libraries
Amstutz, Patrick; Koch, Holger; Binz, H Kaspar; Deuber, Stefan A; Plückthun, Andreas
Abstract: We describe here the rapid selection of specific MAP-kinase binders from a combinatorial library
of designed ankyrin repeat proteins (DARPins). A combined in vitro/in vivo selection approach, based
on ribosome display and the protein fragment complementation assay (PCA), yielded a large number of
different binders that are fully functional in the cellular cytoplasm. Ribosome-display selection pools of
four successive selection rounds were examined to monitor the enrichment of JNK2-specific DARPins.
Surprisingly, only one round of ribosome display with subsequent PCA selection of this pool was necessary
to isolate a first specific binder with micromolar affinity. After only two rounds of ribosome-display
selection followed by PCA, virtually all DARPins showed JNK2-specific binding, with affinities in the
low nanomolar range. The enrichment factor of ribosome display thus approaches 105 per round. In a
second set of experiments, similar results were obtained with the kinases JNK1 and p38 as targets. Again,
almost all investigated DARPins obtained after two rounds of ribosome display showed specific binding to
the targets used, JNK1 or p38. In all three selection experiments the identified DARPins possess very high
specificity for the target kinase. Taken together, the combination of ribosome display and PCA selections
allowed the identification of large pools of binders at unparalleled speed. Furthermore, DARPins are
applicable in intracellular selections and immunoprecipitations from the extract of eukaryotic cells
DOI: https://doi.org/10.1093/protein/gzl004
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-153881
Journal Article
Published Version
Originally published at:
Amstutz, Patrick; Koch, Holger; Binz, H Kaspar; Deuber, Stefan A; Plückthun, Andreas (2006). Rapid
selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries. Protein Engi-
neering, Design Selection, 19(5):219-229.
DOI: https://doi.org/10.1093/protein/gzl004
Rapid selection of specific MAP kinase-binders
from designed ankyrin repeat protein libraries
Patrick Amstutz1,4,5, Holger Koch1,4, H. Kaspar Binz1,
Stefan A. Deuber2 and Andreas Plu¨ckthun1,3
1Biochemisches Institut der Universita¨t Zu¨rich, Winterthurerstrasse 190,
CH-8057 Zu¨rich, Switzerland and 2Institut fu¨r Medizinische Virologie der
Universita¨t Zu¨rich, Gloriastrasse 30, Zu¨rich, Switzerland
3To whom correspondence should be addressed.
E-mail: plueckthun@bioc.unizh.ch
4These authors contributed equally to this work.
5Present address: Molecular Partners AG, c/o Universita¨t Zu¨rich,
Winterthurerstrasse 190, CH-8057 Zu¨rich, Switzerland
We describe here the rapid selection of specificMAP-kinase
binders from a combinatorial library of designed ankyrin
repeat proteins (DARPins).A combined in vitro/in vivo selec-
tion approach, based on ribosome display and the protein
fragment complementation assay (PCA), yielded a large
number of different binders that are fully functional in
the cellular cytoplasm. Ribosome-display selection pools
of four successive selection rounds were examined to
monitor the enrichment of JNK2-specific DARPins.
Surprisingly, only one round of ribosome display with
subsequentPCAselectionof thispoolwasnecessary to isolate
a first specific binder with micromolar affinity. After only
two rounds of ribosome-display selection followed by PCA,
virtually all DARPins showed JNK2-specific binding, with
affinities in the lownanomolar range. The enrichment factor
of ribosome display thus approaches 105 per round. In a
second set of experiments, similar resultswere obtainedwith
thekinases JNK1andp38as targets.Again, almost all invest-
igated DARPins obtained after two rounds of ribosome
display showed specific binding to the targets used, JNK1
or p38. In all three selection experiments the identified
DARPins possess very high specificity for the target kinase.
Taken together, the combination of ribosome display and
PCA selections allowed the identification of large pools of
binders at unparalleled speed. Furthermore, DARPins
areapplicable in intracellular selections and immunoprecip-
itations from the extract of eukaryotic cells.
Keywords: ribosome display/protein fragment
complementation assay/MAP kinase/designed ankyrin repeat
proteins (DARPins)/intrabody
Introduction
To understand the function of proteins, they have to be
studied in their natural environment. A large number of such
experiments depend on reagents for specific molecular
recognition. The most commonly used tools are based on
antibodies, and they have also been used inside cells in
recombinant form (‘intrabodies’) (Lobato and Rabbitts,
2004). However, recombinant antibody fragments are not
ideal for applications in the reducing intracellular environ-
ment, as their stability relies on disulfide bonds that do not
form in this milieu. For this reason, antibodies were
engineered for higher intracellular stability with some success
(Proba et al., 1998; Wo¨rn and Plu¨ckthun, 1998; Desiderio
et al., 2001; Visintin et al., 2002), but the number of selected
and active binders is usually limited (Tanaka and Rabbitts,
2003; Koch et al., 2006). These results can be explained by
the selection pressure, which not only places demands on
specific binding but also requires stability under reducing
conditions.
To overcome these limitations of immunoglobulin
domains, a variety of novel scaffolds for the generation of
antibody-like binding molecules, some of them possessing
very favorable biophysical properties, has been developed
(Nygren and Skerra, 2004; Binz et al., 2005). Designed
ankyrin repeat proteins (DARPins) represent such a novel
scaffold (Binz et al., 2003; Forrer et al., 2003). It has been
shown that DARPins match all requirements for functional
intracellular applications: these molecules can be selected to
bind to any given target protein with high affinity and
specificity, they are very well expressed in the bacterial
cytoplasm and they are stable and cysteine-free (Kohl et al.,
2003; Binz et al., 2004). The selection of DARPins that act as
inhibitors of a bacterial kinase demonstrated their intracel-
lular activity (Amstutz et al., 2005). In this experiment, the
DARPin was selected to inhibit the activity of aminoglyc-
oside phosphotransferase (30)-IIIa (APH), an enzyme
normally mediating kanamycin (kan) resistance, to render
the cells kan-sensitive again. The mechanism of action was
confirmed by the crystal structure of the complex (Kohl et al.,
2005). While the selection of specific in vitro inhibitors from
other scaffold libraries has also been described (Mathonet and
Fastrez, 2004), only few intracellular applications have been
reported (Koide et al., 2002).
We report here the rapid selection of large numbers of
target-specific DARPins and investigate their intracellular
binding-activity, by using a combination of ribosome display
(RD) (Hanes and Plu¨ckthun, 1997), a selection technology
that works entirely in vitro, and the protein fragment
complementation assay (PCA) (Mo¨ssner et al., 2001), an
in vivo selection technology. Briefly, in RD, a library of
mRNA molecules without stop-codon is translated in vitro,
such that the protein of interest remains connected to the
tRNA, and the mRNA also stays connected to the ribosome,
thereby linking genotype and phenotype via the ribosome
(Hanes and Plu¨ckthun, 1997). In the PCA system, two
potentially interacting proteins are co-expressed in Escheri-
chia coli, each fused to one of the complementary halves of
the enzyme dihydrofolate reductase (DHFR). If they interact,
they reconstitute the enzyme, allowing the bacterial cell
harboring the interacting pair to grow on selective media
(Pelletier et al., 1998; 1999; Mo¨ssner et al., 2001).
Three members (JNK1, JNK2, and p38) of the mitogen-
activated protein kinase (MAPK) family were chosen as
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targets. MAPKs are key factors in cellular signal transduction
and are involved in a whole range of diseases, including
cancer and inflammation (Manning and Davis, 2003; Waetzig
and Herdegen, 2005). The investigation of specific MAPKs
is challenging, as these enzymes are highly homologous,
with highly conserved active sites. This problem becomes
even more pronounced for distinguishing members within the
different subfamilies. For example, the JNK subfamily
(Kallunki et al., 1994) consists of three members, JNK1,
JNK2 and JNK3, each with different splice variants (Waetzig
and Herdegen, 2005). While JNK1 and JNK2 are expressed
ubiquitously, JNK3 expression is mostly restricted to the
brain, heart and testis (Gupta et al., 1996). These kinases
mediate the activation of cellular responses to extracellular
signals (Davis, 2000). JNK-dependent signal transduction
is important in a wide range of different cellular processes,
including proliferation, oncogenic transformation, programmed
cell death and many others. While JNK-specific functions are
known, assigning them to the different JNK isoforms is still
difficult. For this purpose, binding molecules that can reliably
differentiate between these isoforms and are functional in the
reducing intracellular environment are needed.
The results obtained with the DARPin library and the
combination of RD and PCA demonstrate that a very large
number of high-affinity MAPK-specific binders, some of
which show high kinase-isoform specificity, were rapidly
selected. All the identified binders were functional in the
cellular cytoplasm. The results also help explain how RD and
PCA complement each other to give an unexpectedly rapid
enrichment of binders.
Materials and methods
Molecular biology
Unless stated otherwise, all experiments were performed
according to standard protocols (Sambrook et al., 1989).
Enzymes and buffers were purchased from New England
Biolabs (Beverly, MA, USA) or Fermentas (Vilnius,
Lithuania). Oligonucleotides were obtained from Microsynth
(Balgach, Switzerland).
Antigen expression and purification
The human MAP kinases JNK1a1 (Swiss-Prot accession
number P45983-2, MK08_HUMAN, short splice form),
JNK2a2 (Swiss-Prot accession number P45984-1,
MK09_HUMAN, long splice form), and mouse p38
(Swiss-Prot accession number P47811-1, MK14_MOUSE,
a-isoform) were used as targets. For some experiments, also
the short splice form JNK2a1 (Swiss-Prot accession number
P45984-2, MK09_HUMAN, short splice form) was used. (An
alignment of the sequences is shown in the Supplementary
Material available at PEDS online). For expression of the
antigen constructs the vectors pAT222 (GenBank accession
AY327137), pAT222_p38 and pAT222_JNK2 (Binz et al.,
2004), as well as pAT222_JNK1 were used. pAT222_JNK1
was constructed by inserting the PCR-amplified JNK1a1
open reading frame [oligonucleotides jnk1f 50-TTC CGC
GGA TCC GGT ACC TCC CGT AGC AAG CGT GAC
AAC-30 and jnk1r 50-AAA CCC AAG CTT GCT GCA CCT
GTG C-30; template pAT58, (Forrer and Jaussi, 1998)] into
pAT222, using the restriction enzymes BamHI and HindIII.
Expression from the vectors pAT222, pAT222_p38,
pAT222_JNK1 and pAT222_JNK2 yields a fusion protein
comprising an N-terminal avi-tag for in vivo biotinylation,
bacteriophage lambda protein D (pD), followed by the target
molecule (or nothing in the case of pAT222), and a C-
terminal His tag for purification (avi-pD-target-His6). The
fusion of a target protein to the well expressed and highly
soluble pD may increase the expression yield of the target
protein (Forrer and Jaussi, 1998). Alternatively, for
expression of His6-tagged JNK2a2 without any further
fusion partner, the vector pQE30_JNK2 was used.
pQE30_JNK2 was constructed by inserting the BamHI/
HindIII JNK2a2 fragment of pAT222_JNK2 into pQE30
(QIAgen, Hilden, Germany). For expressions of His6-tagged
short JNK splice variants (JNK1a1 and JNK2a1) without any
further fusion partner, the vector pQE32 (Qiagen) was used.
For construction of the vectors pQE32_JNK1a1 and
pQE32_JNK2a1, the open reading frames of JNK1a1 and
JNK2a1 were amplified by PCR from the templates
pAT222_JNK1 and pAT222_JNK2 using the following
oligonucleotides: JNK1-Sph-For 50-GCT CAG GCA TGC
TTT CCC GTA GCA AGC GTG AC-30, JNK1-Hind-Back
50-GAG GAT CCA AGC TTC TAT TAT TGC TGC ACC
TGT GCT AAA GG-30, JNK2-Sph-For 50-GCT CAG GCA
TGC TTT CCG ACT CTA AAT GTG ACA G-30, and JNK2-
Hind-Back 50-GAG GAT CCA AGC TTC TAT TAT TGC
TGC ATC TGT GCT GAA GGC TGA TC-30, respectively.
The amplified PCR products of JNK1a1 and JNK2a1 were
then digested with the restriction enzymes SphI and HindIII
and finally ligated into the vector pQE32.
Expression, biotinylation and purification of His6-tagged
proteins pD, pD_JNK1a1, pD_p38, pD_JNK2a2, and non-
biotinylated JNK2 (splice variants a1 and a2) were performed
as described (Binz et al., 2004), whereas non-biotinylated
JNK1a1 was expressed in BL21/pRep4 cells (Qiagen) at
25C. Biotinylation was quantified by using ELISA and
SDS–PAGE, followed by blotting with a streptavidin–
alkaline phosphatase conjugate (Roche, Basel, Switzerland).
In vitro RD selection
The PCR-amplified DARPin libraries were transcribed, and
four selection rounds against the target molecule pD_JNK2a2
as well as two selection rounds against the target molecules
pD_JNK1a1 and pD_p38 were performed as described (Binz
et al., 2004). After each RD selection round the RT–PCR
product of the encoding DARPin pool was analyzed by
agarose gel-electrophoresis. The modular architecture of
DARPins can lead to recombination events during PCR
leading to shortened DARPins. In this study selections were
carried out with a library consisting of three randomized
ankyrin repeat modules between an N-terminal and a C-
terminal capping repeat (denoted N3C). To prevent an
enrichment of molecules which have lost one module (N2C)
by recombination during PCR, the N3C pool of each
selection round was gel-purified prior to re-amplification of
the corresponding DNA. The DNA of each selection round
was finally inserted in the PCA selection plasmid and cloned
by transformation of E.coli XL10 (Stratagene, La Jolla,
CA, USA).
In vivo selection using PCA
The RT–PCR products of each RD selection round, as well as
the naı¨ve DARPin library, were separately amplified by PCR
P.Amstutz et al.
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using the oligonucleotides Ank-Sph-FOR (50-GCT CAG
GCA TGC TTG ACC TGG GTA AGA AAC TGC-30) and
Ank-Eco-BACK (50-GCT GCA GAA TTC TTG CAG GAT
TTC AGC CAG G-30) and inserted via SphI and EcoRI into
the PCA selection plasmid pHK46 (Koch et al., 2006).
Transformation of E.coli XL10 with the ligation products
yielded 2500 colonies for each of the seven DARPin pools
(four JNK2 ribosome-display selection rounds, the naı¨ve
DARPin library, the second one JNK1 ribosome-display
selection round, and the second one p38 ribosome-display
selection round), and virtually no background of re-ligated
vector was observed. The colonies of each transformation
were pooled separately and the plasmids were isolated.
For cloning of the kinase-mDHFRII antigen constructs the
open reading frames of JNK1a1 and p38 were amplified by
PCR from the templates pAT222_JNK1 and pAT222_p38
using the following oligonucleotides: JNK1-Sph-For (see
above), JNK1-Eco-Back 50-GCT GCA GAA TTC TTG CTG
CAC CTG TGC TAA AGG-30, p38-Sph-For 50-GCT CAG
GCA TGC TTT CTC AGG AGC GTC CGA CC-30, and p38-
Eco-Back 50-GCT GCA GAA TTC GGA CTC CAT CTC
TTC TTG G-30, respectively. The amplified PCR products of
JNK1a1 and p38 where then digested with the restriction
enzymes SphI and EcoRI and finally ligated into the vector
pHK43 (Koch et al., 2006), yielding the plasmids pHK95
(JNK1) and pHK96 (p38).
For carrying out the in vivo PCA selection, electrocom-
petent E.coli BL21/pRep4 (Qiagen, Hilden, Germany) cells
(transformation efficiency >3 · 108/mg DNA) were co-
transformed in parallel with 100 ng of each DARPin pool-
mDHFRI and either pHK92 [JNK2a2-mDHFRII fusion
construct (Koch et al., 2006)] or pHK95 and pHK96. After
1 h incubation at 37C, the cells were washed with M9
minimal medium and plated on selective M9 minimal media
supplemented with 50 mg/ml kanamycin (kan, lac-repressor
encoding plasmid pRep4), 100 mg/ml ampicillin (amp,
DARPin-library encoding plasmid), 10 mg/ml chlorampheni-
col (cam, kinase target-encoding plasmid), 2 mg/ml
trimethoprim (TMP, to inhibit bacterial DHFR and select
for functional reassembled mDHFR), 100 mM IPTG, and 5 %
(w/v) of casamino acids (Difco, Detroit, MI, USA) and
incubated at 25C for 72 h.
In parallel to the selective co-transformation, E.coli BL21/
pRep4 was transformed with 100 ng of each DARPin pool-
mDHFRI fusion constructs and incubated overnight at 37C
on standard LB plates (no selection pressure).
ELISA screening to identify specific MAPK-binding DARPins
From the JNK2 selection pools 17 clones each from RD
selection rounds 1, 2 and 4, with or without additional PCA
selection step (Figures 1 and 2) were randomly picked. For
selections on JNK1 and p38, 11 clones from RD selection
round 2, again with or without additional PCA selection step
(Figure 7), were randomly picked. All selected clones were
cultured overnight in 1.2 ml LB (LB, 1% glucose, 100 mg/ml
amp, and 50 mg/ml kan) in 96-deep-well plates (Abgene,
Surrey, UK). On the next day, 300 ml each of these pre-
cultures were added to 1.2 ml LB medium, and incubated at
37C. After 1 h incubation, expression of the DARPin–
mDHFRI fusions was induced by 0.5 mM IPTG, followed by
incubation for 3 h at 37C. The cultures were harvested by
centrifugation and subsequently lysed by shaking for 10 min
in 50 ml B-Per (Pierce, Rockford, IL, USA). After addition of
250 ml TBS500 (50 mM Tris–HCl, pH 7.8, 500 mM NaCl) the
lysed cells were centrifuged again (4 C). One hundred and
fifty microliters supernatant each was transferred to a
MaxiSorp plate (Nunc, Roskilde, Denmark), coated with
either pD or pD_JNK2a2 (for immobilization of pD or
pD_JNK2a2, see Binz et al., 2004) and either BSA,
pD_JNK1a1, pD_JNK2a2, or pD_p38. After incubation for
45 min at 4 C, DARPin–mDHFRI fusions were detected
using an anti-RGS(His)6-antibody as described (Binz et al.,
2004).
Expression and purification of selected JNK2-specific DARPins
DNA encoding the selected DARPins were PCR-amplified
using oligonucleotides Ank-Sph-FOR and Ank-Hind-BACK
(50-GAG GAT CCA AGC TTC TAT TAT TGC AGG ATT
TCA GCC AGG TC-30) and inserted via SphI and HindIII
into the expression vector pQE32 (Qiagen), which is the PCA
selection plasmid without the mDHFR fusion protein.
Successful cloning was verified by DNA sequencing.
Expression and purification of the DARPins was carried
out as described (Kohl et al., 2003). Purity of the samples
was assessed by SDS–PAGE, and concentrations were
determined by UV absorbance at 280 nm.
Specificity of selected JNK2-specific DARPins
The biotinylated proteins JNK2a2, JNK1a1 and p38 were
immobilized on neutravidin-coated MaxiSorp plates (Nunc,
Roskilde, Denmark) as described (Binz et al., 2004). One
hundred microliters of selected and purified DARPins
(250 nM) were incubated in TBST (50 mM Tris–HCl, pH
7.8, 150 mM NaCl, 0.05% Tween, and 0.5% BSA) in each
well for 30 min at 4 C. In addition, one unselected DARPin
(100 ml 250 nM E3_5, see Binz et al., 2003) and two anti-
JNK antibodies (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) in a dilution of 1:500 (dilution recommended by the
supplier) in TBST served as controls (anti-JNK1 antibody
C17/sc-474 and anti-JNK2 antibody N18/sc-827). Further-
more, one aliquot of each binder (DARPin and antibodies)
was additionally pre-incubated for 2 h with 750 nM free
JNK2a2 prior to incubation with the immobilized antigen
(Figure 4A). Clone pB4 was applied at higher concentrations
(5 mM purified DARPin; inhibited with 15 mM free JNK2a2).
In the second ELISA (Figure 4B), binding of only the
selected DARPins (250 nM) to immobilized JNK2a2 was
inhibited with free JNK2a2, JNK2a1 and JNK1a1 (750 nM
each). Again, DARPin pB4 was applied at higher
concentrations (5 mM purified DARPin; inhibited with 15
mM free JNK2a2, JNK2a1 and JNK1a1). In both ELISAs,
binding of the selected DARPins was analyzed by detection
of their N-terminal RGS(His)6 motif as described (Binz et al.,
2004). Binding of the purchased anti-JNK antibodies was
detected by a goat anti-rabbit IgG-AP antibody conjugate
[100 ml/well, 1:3000, 45 min; Sigma (St Louis, MO, USA)].
After extensive washing, the bound DARPins as well as the
purchased anti-JNK antibodies were visualized using 4-
nitrophenyl phosphate (3 mM 4-NPP, 50 mM NaHCO3, and
50 mM MgCl2 in H2O; 100 ml/well). Absorbance was
measured at a wavelength of 405 nm. All measurements were
performed in duplicates.
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Surface plasmon resonance
Surface plasmon resonance (SPR) was measured using a
BIAcore 3000 instrument (BIAcore, Uppsala, Sweden). All
measurements were done in HBS buffer (20 mM HEPES pH
7.4, 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, 0.005% Tween
20) at a flow rate of 50 ml/min. Biotinylated pD_JNK2a2
fusion protein was immobilized (600 RU) on a SA chip
(BIAcore). For the determination of kinetic data, the
interactions were measured as follows: 5 min initial buffer
flow, followed by a 3 min injection of DARPin in varying
concentrations (1–200 nM) and a final off-rate measurement
of 45 min with buffer flow. DARPin pB4 was measured at
higher concentrations (50 nM to 1 mM) using a shorter
dissociation time (15 min). The signal of an uncoated
reference cell was always subtracted from the sensorgrams.
The kinetic data of the interaction were evaluated with a
global fit using BIAevaluation 3.1 (BIAcore).
Affinity precipitation
Human embryo kidney cells (HEK-293T) were lysed in cold
lysis buffer (20 mM Tris pH 7.7, 2 mM MgCl2, 50 mM KCl,
0.1 mM EDTA, 1.0% Triton X-100) and shaken for 10 min at
4C. The lysate was cleared by centrifugation at 14 000 r.p.m.
for 15 min at 4C. Ni-NTA agarose beads (16 ml of a 50% (v/
v) suspension, Qiagen) were washed three times with 500 ml
cold lysis buffer. The purified recombinant DARPins (2 mg
per assay) were coupled to the beads for 1 h at 4C. The
beads were washed again, and non-specific binding sites of
the beads were saturated by incubation with 0.5% BSA for
30 min. Again the beads were washed three times with cold
lysis buffer. Five hundred microliters cleared cell lysate per
assay (1 mg of total protein) was added to the prepared beads.
Binding of DARPins was taking place while tumbling on a
rotation wheel at 4C for 2 h. The beads were washed three
times with ice-cold lysis buffer followed by a final wash in
TBS. Proteins bound to the beads were eluted in 40 ml elution
buffer (50 mM sodium phosphate, pH 8.0, 300 mM NaCl,
250 mM imidazole). To the eluate 12.5 ml 4· loading buffer
was added and heated to 95C. Ten microliters of the sample
was added per lane and separated by SDS–PAGE on a 10%
(for JNK2) or 15% (for ankyrin repeat proteins) gel. As a
control for the total cell lysate, 2 ml were loaded. Endogenous
JNK2 and the recombinant DARPins were detected by
Fig. 1. Schematic representation of the selection and analysis strategy. (A) JNK2 selection. (B) JNK1 and p38 selection.
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western blotting. Primary antibodies against SAPK/JNK (Cell
Signaling, Catalog No. 9252) and against the RGS-His tag
(Qiagen) were used, respectively. Secondary anti-mouse
antibodies were visualized by enhanced chemiluminescence
(Amersham Biosciences).
Results
The goal of this project was the selection of DARPins
binding to MAP kinases with high specificity and to test the
functionality of the selected DARPins in vitro as well as
in vivo. At the same time, the selection process was
monitored. For initial selections of binding molecules from
large DARPin libraries, RD (Hanes and Plu¨ckthun, 1997) was
applied. This complete in vitro selection technology
circumvents any library-size limiting transformation step
and is thus ideally suited to handle large libraries (diversity
>1010). PCA, a bacterial intracellular selection technology,
based on the reconstitution of DHFR activity from the
divided enzyme by two interacting partners (Pelletier et al.,
1998, 1999; Mo¨ssner et al., 2001), was subsequently applied
to analyze the RD generated pools of binders (Figure 1) and to
further enrich these binders. This assay, taking place in the
bacterial cytoplasm, also demonstrates DARPin activity under
reducing conditions. Selected DARPins were further examined
for their target binding properties with respect to specificity and
affinity in ELISA, SPR, and affinity precipitation experiments.
In vitro and in vivo selection of JNK2-binding DARPins
For the selection of JNK2-specific binders from an N3C
DARPin library, four standard RD selection rounds (Hanes
and Plu¨ckthun, 1997) against immobilized JNK2a2 (long
splice variant of JNK2) were performed (for an explanation
of the nomenclature N3C, see Materials and Methods). The
alignment of the short and long splice variants of the MAP
kinases used in this study are shown in the Supplementary
Material available at PEDS online. A pool of DNA fragments
encoding DARPins (2500 individual clones) from the naive
starting library and from each RD selection round was
inserted into the PCA selection plasmid as a mDHFRI fusion.
In parallel experiments, co-transformation of these pools with
the JNK2a2-mDHFRII-bait-plasmid allowed determination of
the bacterial survival under selective conditions as a function
of the respective RD selection round (Figure 2).
As expected, nearly no bacterial colonies resulted from co-
transformation of the bait-plasmid with the naive DARPin
library. The pool after the first round of RD also gave rise to
almost no colonies under selective PCA conditions (i.e. in the
presence of TMP to inhibit bacterial DHFR). In contrast,
co-transformations of the DARPin pools corresponding to RD
selection rounds 2, 3 and 4 gave rise to a large number of
bacterial survivors, which increased with the selection round
number (Figure 2). As a control, the individual pools were
also plated under non-selective conditions with no TMP
present, where no difference in colony numbers was
observed, indicating that all pools had been treated equally
(data not shown). These results suggest that two rounds of
RD are sufficient for selection of binders.
ELISA screen to identify JNK2-specific DARPins
To elucidate whether the increased colony number, observed
in the in vivo PCA selection, did indeed result from an
enrichment of JNK2-specific DARPins, the binding of the
selected DARPins to JNK2a2 was tested in ELISA screens.
Seventeen clones from each of the selection rounds 1, 2 and
4, obtained either after growth on selective media for PCA
selection or from colonies grown on non-selective plates,
were randomly picked. Crude E.coli extracts from small-scale
expression cultures were used in ELISA experiments to
compare the binding of the selected clones either to JNK2a2
or, as a control, to the pD (Figure 3).
Of the DARPins, which were selected by RD without
subsequent PCA step, no JNK2-specific DARPin was found
in the pool from selection round 1, whereas 30% of the
DARPins of both the selection rounds 2 and 4 showed JNK2-
binding. In comparison, when a PCA selection was carried
out after the first RD selection round, one JNK2 binder was
already obtained. Furthermore, 80% of the DARPins of
round 2 and nearly 100% of the DARPins of round 4 showed
binding to JNK2, when the RD rounds were followed by a
PCA selection. It seems that RD is afflicted with an intrinsic
background, which cannot be reduced by further RD selection
rounds. Thus, the expression plasmids which were obtained
by ligation of the RD product, encode a constant percentage
of non-binders. Typical values of 10–70% non-binders (see
also below for the second set of experiments) have been
found in other experiments. In contrast, when the same pools
are sieved by an additional PCA selection, already after the
second round of RD, the majority of clones are specific
binders. PCA alone, on the other hand, suffers from a
background of false positives, if selections are carried out
with naı¨ve libraries (Koch et al., 2006).
We have thus used PCA as a tool to analyze the progress
of the RD selection from round to round. The enrichment in
RD is much faster than previously assumed. However, it does
not reach a level of 100% binders by itself: the errors
introduced by PCR, point mutations and recombination
events (see below), that make RD so attractive as an
evolution technology also cause a constant background of
non-binders. On the other hand, we can use PCA also as an
Fig. 2. In vivo PCA screen after each JNK2 ribosome-display selection round.
The unselected DARPin library and the DARPin pools obtained after each round
of RD selection were cloned as N-terminal mDHFRI fusion (see Materials and
Methods) and co-transformed in E.coli with the JNK2a2-mDHFRII antigen
construct under selective conditions. Co-transformation of the naive DARPin
library or the DARPin pool of the 1st RD selection round with the JNK2-DHFRII
encoding plasmid gave a similar, low level of colony forming units. In contrast,
increasing numbers of colonies are observed from co-transformation of the
DARPin pools of RD selection rounds 2, 3 and 4. Under non-selective growth
conditions, similar numbers of colonies were obtained.
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integral part of the selection procedure. As the RD-selected
pool must be cloned anyway by ligation of the PCR product
and transformation of bacteria, the workload remains
identical, just a different vector and selective media for
plating the bacteria is used.
Sequencing of the JNK2-specific DARPins
Thirty-four DARPins were chosen for sequencing (10 binders
from the RD-only selection and 24 binders from the
combined RD/PCA selection). Three binders were found
multiple times, but only in the selection that combined RD
with PCA (pB4 = pC4 = pD4, pF6 = pG6, pF7 = pA12;
Figure 3). In addition, two binders were found in either
selection (pE8 = rC6, pF7 = pA12 = rD12).
Despite the occurrence of duplicate clones, the total
number of different binders found after each round of RD is
somewhat larger with the additional PCA step. The main
reason is that, in the absence of PCA, a constant fraction of
non-binders are found, while in the presence of PCA, the
non-binders have all been removed. We have not detected
any notable feature that would explain multiple appearance
of certain clones (affinity, solubility or expression yield) and
cannot exclude a mere statistical effect.
Of the non-binder population, 13 clones without and
13 clones with additional PCA selection were sequenced. In
this group, no deletions, premature stop codons or frame
shifts were detected. However, a substantial variation of
DARPin sizes, ranging from one (N1C) to five (N5C) internal
repeats was found among the non-functional molecules. This
finding strongly suggests that recombination events, as
discussed above, had taken place during RT–PCR. The power
of selection for specific binding keeps the functional
molecules to an appropriate size however. Note that this
RT–PCR is necessary after the final isolation of mRNA in RD
before ligating it into a plasmid which is in turn necessary for
the characterization of single clones, isolated from bacteria.
When monitoring the outcome of the RT–PCR after a
RD selection round by agarose gel-electrophoresis, a certain
proportion of the DARPins were found to be shortened by
one AR module (N2C instead of N3C). This shortening
was found for 10% of the RD selected DARPins, but,
surprisingly, for 50% of the DARPins resulting from the
subsequent PCA screen. This observation might indicate a
growth advantage of the N2C DARPins over the N3C
molecules in the context of the JNK2 PCA selection. This
phenomenon has, however, not been observed in the second
set of selections (see below).
In conclusion, from 34 sequenced JNK2-binding DARPins,
28 different DARPins were identified, indicating that the
generated binder pool still holds substantial diversity.
Fig. 3. ELISA screen to identify JNK2-specific DARPins. The JNK2-binding of randomly picked DARPins of different RD selection rounds (with or without
additional PCA selection step) are compared. Crude cell extracts of E.coli expressing the DARPins as mDHFRI fusions were applied to wells coated with JNK2a2
(black columns) or pD (control; white columns). No JNK2-specific DARPin was identified from selection round 1 of the RD selection, whereas three JNK2-specific
DARPin clones (determined to have the identical sequence) were found in round 1, when followed by an additional PCA selection. From the groups of DARPins
originating from RD selection rounds 2 and 4, 30% possess JNK2 specificity. Again, many more JNK2-specific DARPins were identified from the corresponding
selection rounds, when an additional PCA selection was carried out: 80% of the DARPins of round 2, and nearly all DARPins of round 4 show specific binding to
JNK2. All the binders, which were chosen for further characterization, are marked bold (pB4 = pC4 = pD4; rD12 = pF7 = pA12). It can be seen that the performance of
the additional PCA screen leads to a much stronger enrichment of JNK2-specific DARPins in all selection rounds evaluated.
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Affinity of selected JNK2-specific DARPins
Target binding of six different JNK2-binding DARPins was
characterized by SPR and by ELISA experiments. Binders
from the different selection rounds, with and without
additional PCA-selection step, were included (Figure 3).
Kinetic SPR measurements on a Biacore instrument using
multiple concentrations of the selected DARPins were used to
determine their dissociation constants with a global fit
(Table I). (The global fits are shown in the Supplementary
Material available at PEDS online). While the KD of pB4, the
only clone that resulted from the first selection round, was
around 1 mM, all other binders had low nanomolar affinities.
Interestingly, the affinity of binders from selection round 2
already equal the ones found from selection round 4. Binders
generated with or without additional PCA selection seemed to
bind with similar affinities (Table I). As PCA yielded binders
possessing affinities ranging from the micromolar (first
round) to the nanomolar range (subsequent rounds), it seems
that the PCA selection system can tolerate a broad spectrum
of affinities, all resulting in bacterial growth. PCA functions
thus as a qualitative ‘gate’ in this system (see Discussion).
Specificity of selected JNK2-specific DARPins
ELISA experiments were carried out to investigate the
specificity of the JNK2 binders. In a first ELISA experiment
the binding of the DARPins to JNK2a2 (long splice variant)
was compared with that to JNK1a1 (short splice variant) and
p38 (for an alignment of the three kinases and their splice
forms, see Supplementary Material available at PEDS
online). While JNK2 and JNK1 share 81% identity and
86% similarity, JNK2 and p38 still share 51% identity and
59% similarity on the amino acid level. As a control, two
commercially available antibodies (see Materials and
Methods), one raised against JNK1, the other against
JNK2, were tested in parallel. All DARPins and the JNK1
antibody were highly specific for their cognate antigen, while
the anti-JNK2 antibody seemed to not discriminate between
JNK1 and JNK2 (Figure 4). None of the binding proteins
interacted with p38.
To investigate the isoform specificity of the selected
DARPins, competition ELISAs were performed. For this
purpose JNK2a2 (long splice variant) was immobilized, and
the binding of the DARPins was competed with free JNK2a2,
JNK2a1 (short splice variant) or JNK1a1 (short splice
variant). As expected, the binding of all DARPins was
inhibited by JNK2a2, which was the target used for selection.
Most DARPins (pG7, pB8, pB11, pE11) were also inhibited
by JNK2a1. While the inhibition of DARPin pE11 was equal
for both long and short isoforms of JNK2, the others (pG7,
pB8, pB11) were inhibited less by the short JNK2 splice
variant. This might be explained by the binding epitope
residing partly on the extension that characterizes the long
isoform, or, alternatively, by the two splice variants being
present in two different conformations, of which the one of
JNK2a2 is bound with higher affinity. All DARPins were not
or only weakly inhibited by the short splice variant of JNK1
Table I. Affinity of selected JNK2-specific DARPinsa
Clone Round Selection Size kon (M
1s1) koff (s
1) KD (nM)
pB4 1 RD and PCA N2C (4.1 6 2.2) · 104 0.0342 6 0.0041 914 6 568
pB8 2 RD and PCA N2C (1.4 6 0.6) · 105 (9.2 6 2.9) · 104 6.5 6 4.3
pG7 2 RD and PCA N3C (3.5 6 1.3) · 105 (4.0 6 0.6) · 103 11.3 6 5.9
pB11 4 RD and PCA N3C (2.0 6 0.5) · 105 (4.0 6 0.6) · 103 22.0 6 9.8
pE11 4 RD and PCA N2C (4.2 6 1.5) · 105 (9.6 6 0.7) · 104 2.3 6 1.0
rD12 4 RD N2C (4.7 6 0.2) · 105 (6.8 6 0.9) · 104 1.4 6 0.3
aKinetic SPR measurements. The global fits can be found in the supplementary data of PEDS online.
Fig. 4. Specificity comparison of JNK2-selected DARPins by ELISA. (A)
Binding of different selected DARPins to JNK2a2, JNK1a1 and p38 is com-
pared. Two commercially available antibodies (sc C17 and sc N18, see Materials
and Methods) and one unselected DARPin (E3_5) were included as controls.
Because of its lower affinity DARPin pB4 (obtained after only one round of RD)
was applied at a concentration of 5 mM, compared with 250 nM for all other
DARPins (A and B). All selected DARPins and the JNK1 antibody (sc C17) were
highly specific for their respective antigen in immobilized form, while the anti-
JNK2 antibody (sc N18) does not discriminate between the JNK homologs. The
unselected DARPin (E3_5) does not bind to any of the antigens. Furthermore,
none of the tested binding proteins show an interaction with p38. (B) A com-
petition ELISA including the different JNK splice variants was used to evaluate
the specificity. The black bars indicate the signal in the absence of competitor.
All binders were inhibited by a 3-fold excess of free JNK2a2 (final concentration
750 nM). The same amount of JNKa1 had only a minor inhibitory effect on
JNKa2 binding. DARPin pE11 was equally well inhibited by the long and the
short splice variant of JNK2, while not inhibited by JNK1, indicating a very high
specificity.
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(JNK1a1). Thus, the DARPins recognize various features
discriminating long and short splice variants and JNK1a1 and
JNK2a1. Furthermore, pE11 discriminates JNK1 and JNK2
both in direct binding and competition ELISA.
JNK affinity precipitation with selected JNK2-specific DARPins
In order to test whether the selected DARPins bind to JNK in
eukaryotic cells, some of the JNK2-specific binders were
tested in affinity precipitation experiments from different cell
lines. Lysed cells were incubated with His-tagged DARPins,
which were subsequently captured by Ni-NTA beads. The
affinity precipitated JNK was detected on western blots with
JNK-specific antibodies. All the tested DARPins (pG7, pE11,
rD12) precipitated JNK from the cell lysate, giving rise to the
corresponding bands on the western blot, while the controls,
the non-binding DARPin E3_5 and beads with no DARPin,
did not (Figure 5). Both short and long splice variants were
precipitated, while the short form predominated. This most
likely reflects the ratio of the JNK variants present in the cell
lysate. From other cell lines, the large variant was
predominately detected by this affinity precipitation and
western blot (data not shown). In all tests, the three JNK2-
binding tested DARPins gave the same results with respect to
the abundance of long and short splice variants. This was not
expected from the ELISA experiments, where pG7 and rD12
showed preferences towards the long variant, while pE11
bound both with equal affinity, but we do not know the
stoichiometries in the experiment. The affinity precipitation
experiments do not allow any conclusions with regard to
specificity toward JNK1 and JNK2, as the detection antibody
does not allow differentiating between the different JNK
homologs.
Selection and characterization of JNK1- and
p38-binding DARPins
To elucidate whether two rounds of RD are sufficient in
general to obtain antigen-specific DARPins when cloning of
the RD-pools is followed by subsequent PCA selection,
additional RD selections against immobilized JNK1a1 and
immobilized p38 were carried out. Again, the pools of DNA
fragments encoding 2500 individual DARPins obtained after
the second round of RD were inserted into the PCA selection
plasmid as mDHFRI fusion. The pools (including the JNK2
pool from the first set of experiments) were co-transformed
with the cognate kinase and the respective other two kinases
as mDHFRII-fusions. As can be seen in Figure 6, the DARPin
pools selected against JNK1 and p38 are highly specific for
their cognate target kinase, while the JNK2-selected DARPin
pool shows some cross-reactivity with JNK1.
Eleven clones from each of the JNK1 and p38 selections
obtained either with additional PCA selection or from
colonies grown on non-selective plates were randomly picked
to inoculate small-scale expression cultures. Crude E.coli
extracts from these expression cultures were then used in
ELISA experiments to compare the binding of the selected
clones either to BSA, JNK1a1, JNK2a2 or p38 (Figure 7). Of
the DARPins which were exclusively selected by RD, 60%
of the JNK1-selected clones showed JNK1 binding, while
only 10% of the p38-selected clones bound to p38. In
comparison, when a subsequent PCA selection was carried
out, the proportion of identified binders increased to 100% for
the JNK1-selected clones and to 50% for the p38-selected
clones on their respective cognate antigen. Thus, for all
investigated selection experiments the percentage of binders
was increased when the RD rounds were followed by a PCA
selection. Furthermore, with the exception for one clone
Fig. 5. Affinity precipitation. (A) JNK was immunoprecipitated from human
embryo kidney (HEK) cells by selected JNK2-binding DARPins and detected
by western blot using a JNK-specific antibody. All tested DARPins (pG7, pE11,
rD12) lead to detection of bands on the blot that correspond to JNK, while the
controls, non-binding DARPin E3_5 and beads with no DARPin, did not. Both
short and long splice variants were precipitated. The MW of the splice forms of
JNK2 are 46 and 54 kDa (see Supplementary Material available atPEDSonline).
With respect to specificity for JNK1 or JNK2 in the affinity precipitation
experiments no conclusions can be drawn, as the detection antibody does not
allow differentiating between the JNK homologs. (B) The presence of the
DARPins was confirmed by western blotting (detection of the his-tag).
Fig. 6. Co-transformation of the RD-selected DARPin pools (2nd RD selection
round) with their respective cognate target kinase and two unrelated kinases.
All co-transformations were plated on selection media containing 0.1 mM IPTG
and incubated for 72 h at 25C. The DARPins pools selected against JNK1
and p38 can be seen to be highly specific for their cognate target kinase, while
the JNK2-selected DARPin pool shows some cross-reactivity with JNK1.
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(p38r4), all antigen-binding DARPins were highly specific for
the respective target kinase, and did not show binding to the
other immobilized members of the MAP-kinase family
(Figure 7).
From the group of JNK1-specific DARPins, which were
identified in the ELISA screen, five DARPins resulting from
RD only and eleven DARPins obtained from the combined
RD/PCA selection were chosen for DNA sequencing. From
the five JNK1 binders that were selected only by RD none
was found multiple times, whereas two of the DARPins that
were identified after additional PCA selection were found
multiple times (J1p3 = J1p7 and J1p1 = J1p8 = J1p10 =
J1p11). None of the six sequenced p38-binding DARPins was
found multiple times. (For sequences of the selected DAR-
Pins, see Supplementary Material available at PEDS online).
In contrast to the sequencing results of the JNK2-specific
DARPins, none of the selected p38 binders and only one of
the JNK1 binders (J1r5) was shortened by one AR module
(N2C instead of N3C).
As 18 of the 22 sequenced JNK1- and p38-binding
DARPins are different, the generated binder pools hold again
a substantial diversity. Thus, our results indicate that two
rounds of RD are indeed sufficient to select highly specific
and highly diverse DARPin pools.
Discussion
We demonstrate here the selection of a large pool of
DARPins binding to MAP kinases with high specificity and
affinities. For the generation of kinase-specific DARPins a
combined in vitro and in vivo selection was performed. RD
was applied for the selection of kinase binders from a large
combinatorial DARPin library. PCA was used to monitor the
RD selection process and to further enrich specific DARPins
from the pools of binders generated by RD. This assay also
served to test the functionality of the selected DARPins under
reducing conditions in the bacterial cytoplasm. Affinity
precipitation from mammalian cell lysates demonstrated
another application of DARPins.
The analysis of the binders from different selection rounds
showed that the selection process of kinase-specific DARPins
was extremely rapid. In three independent selection
experiments two rounds of RD were sufficient for enrichment
of a variety of different kinase-specific DARPins with
nanomolar affinities. These results suggest that the
combination of the DARPin library with both RD and
PCA selections is very suitable to rapidly generate diverse
pools of specific binders, fully functional under reducing
conditions. The pools can then be used as starting points to
screen for functionality for a range of different applications,
including intracellular ones.
Targeting kinases—an issue of specificity
About 518 human protein kinases are currently known
(Manning et al., 2002). Most of these are part of complex
signaling cascades, and the different kinases often share very
high homology. This homology complicates the selection of
specific eukaryotic protein kinase (EPK) binders. To address
EPK function, often binders and inhibitors are used which
lack sufficient specificity, and thus the observed effects
cannot be allocated correctly. All selected DARPin binders
reported here were highly target kinase-specific. One binder
(pE11) seemed to discriminate between JNK1 and JNK2 in
direct and in inhibition ELISA, despite 80% identity of the
Fig. 7. ELISA screen to identify JNK1- and p38-specific DARPins. The binding of randomly picked DARPins of the 2nd RD selection round obtained from selections
against either JNK1 or p38 (with or without additional PCA selection step) to different MAP kinases is compared. Crude cell extracts ofE.coli expressing the DARPins
as mDHFRI fusions were applied to wells coated with BSA or JNK1a1, JNK2a2, and p38. From the groups of DARPins originating from only RD selection,60% of
the constructs show binding to JNK1 whereas only 10% of the clones show binding to p38. In both experiments a higher percentage of cognate DARPins, recognizing
JNK1 (100%) or p38 (50%) were identified when an additional PCA selection was carried out. With exception of the clone p38r4 all identified binders show highly
specific binding to only the MAP-kinase they have been selected against.
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target proteins. This high specificity of DARPins may be a
useful feature in the quest to understand the function of
individual kinases in more detail.
We believe that the high specificity of the selected
DARPins is based on two components: the binding epitope
and the binding mode. Most peptides and small molecules
used to date bind EPKs in grooves (Noble et al., 2004). These
grooves, especially the active site, are often highly conserved,
preventing specific targeting. As the randomized DARPin
surface is comparatively flat, the selected binders will interact
with the target protein on exposed surface areas. These
surface areas are more likely to be kinase-specific, and thus
specificity is achieved more easily. From the crystal
structures of DARPin library members, unselected or in
complex with the target (Kohl et al., 2003; Binz et al., 2004),
we know that the DARPin behaves essentially like a rigid
body and does not bind to groves or pockets on the targets,
but rather to surface structures. This might restrict the
compatible binding epitopes, but results in very high
specificity, as the DARPin will not adapt to conformations of
other proteins.
Selection by a combination of RD and PCA
We have used a combination of RD and PCA, in which PCA
was used, on the one hand, as an analytical tool to monitor
the progress of RD, and on the other hand, as an additional
‘gate’ to increase the proportion of binders. We found that
one round of RD can be enough to find some binders, if the
RD selection is followed by a PCA ‘gate’. Because of the
sparse sampling at this point (see below), this binder has only
micromolar affinity. It takes only one additional round of RD
alone, however, to obtain binders of low nanomolar affinity.
If RD is thus combined with the PCA ‘gate’, then all binders
may already have these properties, and there is no discernable
improvement of affinities from round 2 to round 4.
This surprisingly rapid selection also guarantees the
maintenance of high diversity: of 56 sequenced binders,
46 were different. In selections of antibody libraries with
RD alone, more rounds were necessary, and then a decrease
of diversity became noticeable (Hanes et al., 2000). Clearly,
the high diversity of high-affinity binders is an important
prerequisite to use them as starting points for selection for
function. The selection of DARPins inhibiting a prokaryotic
kinase, which is structurally homologous to MAP kinases,
has recently been carried out (Amstutz et al., 2005) and
the inhibition mechanism was visualized by the structure
determination of the complex (Kohl et al., 2005).
The main functioning of the additional PCA step is that of
a ‘gate’. The PCA selection requires only a micromolar
interaction (KD of pB4, Table I and Figure 3), but it rather
effectively removes those clones which do not express
binders (Figures 3 and 7). Such non-binders can end up in a
selected plasmid by two mechanisms. First, mRNA encoding
non-binders can still be present in the target-bound fraction
after RD. Second, new non-binders can be generated via
mutation in the RT–PCR following mRNA isolation, as
this PCR step is necessary for cloning. We presume that the
latter is an important mechanism contributing to non-binders
as it would explain why one cannot obtain 100% binders
with additional rounds. We would stress that this finding is
not an impediment of the RD method: a great diversity of
clones with high affinity and specificity is always found, and
the final percentage of binders is high enough that ELISA
screening is very convenient.
The gating function of PCA is illustrated in the outcome of
the first round of RD. Binders are rare among the DARPins,
as expected from a diverse library, and it is the large size of
the library that allows the selection of such binders. PCA
alone does not allow the easy identification of such binders,
as non-specific interactions occur in vivo that lead to cell
growth of the naı¨ve library and after one round of RD
(Figure 3). Importantly, such non-specific binders are also
extremely rare, as the very small number of colony forming
units show. As soon as RD has enriched ‘real’ binders above
this background, PCA can be used to reliably identify
binders, as by then, background clones are so rare among
growing colonies that they are negligible. This ‘cross-over’
point seems to be reached already after one round of RD. The
binders obtained at this stage are not yet of high affinity. The
most likely explanation is a statistical one: the sampling of
binders is so sparse at this stage that it is likely that anyone
that is found will be of low affinity, of which there will be a
greater number than those with high affinity. Since only a
small subset of the large RD library was cloned, statistically
not many binders can be expected. Importantly, it takes only
one additional round of RD, until the identified binders are all
of low nanomolar affinity (Table I).
We believe that RD for selecting large pools of binders in
combination with PCA for sieving these pools is an ideal
combination for rapid identification of many different
binders. This combination of in vitro selection (by phage
display) and a subsequent in vivo screen (by the yeast two-
hybrid system) has also been described for the selection of
antibody fragments active inside cells (Visintin et al., 2002;
Tanaka and Rabbitts, 2003). By this combination, only very
stable antibodies survived selection in the reducing
intracellular environment, and many binders might be lost
due to insufficient stability. DARPins are stable per se under
reducing conditions and therefore, probably no binders will
be lost in the second in vivo selection step. Instead, the
selected binder pool is ‘cleaned up’ from PCR errors by PCA,
and at the same time, non-specific in vivo interactions no
longer play a significant role in PCA, as enriched binders
outnumber them.
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